Haloperidol in palliative care: Indications and risks - 18/11/20

pages | 8 |
Iconographies | 3 |
Vidéos | 0 |
Autres | 0 |
Graphical abstract |
Highlights |
• | Progress in medicine may prolong lives of patients with chronic, incurable diseases. |
• | Long aggressive treatment increases the risk of multiorgan insufficiency. |
• | Haloperidol is used in palliative care symptomatic treatment to ensure quality of life. |
• | Haloperidol is effective but risky in palliative care. |
• | Selected patients need Haloperidol dose adjustment. |
Abstract |
Individual response to medication depends on several factors (age, gender, body weight, general clinical condition, genetics, diet, hydration status, comorbidities, co-administered drugs and their mode of administration, smoking, alcohol overuse, environmental factors, e.g. sunlight) that may contribute to adverse drug reactions even at therapeutic doses. Patients in palliative care are at increased risk of these reactions. Unwanted drug effects diminish the quality of life and may lead to a suboptimal dying process. Haloperidol is one of the three most commonly used drugs in palliative care and the most commonly employed typical antipsychotic. It has also been recommended for inclusion into the palliative care emergency kit of home care teams. As such, it is important to be fully conversant with the indications, benefits, and risks of haloperidol, especially in the context of palliative care.
Le texte complet de cet article est disponible en PDF.Keywords : Haloperidol, Palliative care, Cardiotoxicity, Adverse effect, Neurotoxicity
Plan
Vol 132
Article 110772- décembre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?